| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ce7c1ce7f7821f5e083dae8d241cc3d7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_fb1aa649f860b8e3f59582fcf36fb6ff |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-44 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P41-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K33-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0024
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K33-42 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N1-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N1-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K33-42
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P41-00 |
| filingDate |
2008-03-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_57bbeb0e97f353db07c03102152c56fb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3a2260fcad4811e423be7d743485bf40 |
| publicationDate |
2008-10-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2008121328-A2 |
| titleOfInvention |
Fluid composition for inhibiting surgical adhesion formation and related method of production |
| abstract |
A composition to inhibit the formation of adhesions that may arise at a surgical site. The composition includes an antioxidant in a carrier. The carrier is comprised of cocamide diethanolamine, diethanolamine and glycerin. The composition may include additional additives, such as euricamide and a compound including a polyethylene resin, calcium carbonate and a concentrated form of the carrier. The composition is produced by heating the carrier to a temperature, preferably about 375°F and then adding the additives. The mixture is heated at temperature long enough to cause the antioxidant to leach into the liquid. The mixture is then cooled at room temperature and maintained in liquid form for ease of application to the surgical site where adhesion formation inhibition is desired. The composition is preferably degradable in vivo. |
| priorityDate |
2007-03-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |